Dna Seq 2, Inc. funding
Dna Seq 2, Inc., a pharmaceuticals company based in Vista, CA (founded 2022), filed a Form D with the SEC on March 11, 2026 and reported $1.2M raised.
Amount raised$1.2M
Offering size$1.2M
Filed with the SECMarch 11, 2026
First saleApril 10, 2024
IndustryPharmaceuticals
SecuritiesEquity
LocationVista, CA
Founded2022
Entity typeCorporation
Investors so far32
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Mar 11
Other health care rounds in California
Alpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyCaspian Therapeutics, Inc.$50M · Sep 23BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyPFARADIGM Health, Inc.$31.1M · Sep 28Other Health CareTrellis Bioscience, Inc.$22.9M · Oct 21BiotechnologyAltay Therapeutics, Inc.$15.7M · Oct 2BiotechnologyAdela, Inc.$12M · Oct 19Biotechnology